Hepatitis B surface antigen (HBsAg) prevalence in Madagascar
Madagascar: Hepatitis B surface antigen (HBsAg) prevalence was 0.6% in 2024. ▼ Falling
Latest (2024)
0.6%
Change on year
up 20.0%
World rank
51st
of 192 countries
All-time high
0.7%
in 2015
All-time low
0.5%
in 2020
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Madagascar, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Madagascar recorded 0.6% for hepatitis b surface antigen (hbsag) prevalence in 2024.
Compared with earlier readings it is up 20.0% on the previous year and down 14.3% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Madagascar peaked at 0.7% in 2015 and was at its lowest, 0.5%, in 2020.
That places Madagascar 51st out of 192 countries with data for 2024, putting it in the middle of the range.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.6% | 0.6% | 0.7% | 5 |
| 2020s | 0.5% | 0.5% | 0.6% | 5 |
Countries ranked near Madagascar
- 51 Tonga 0.6% compare
- 51 Côte d'Ivoire 0.6% compare
- 51 Ethiopia 0.6% compare
- 51 Micronesia 0.6% compare
- 51 Lao People's Democratic Republic 0.6% compare
- 51 Nauru 0.6% compare
- 51 Palau 0.6% compare
More health data for Madagascar
- Un projection of annual infant deaths, annual growth rate -1.87 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4912 % change on previous year (2090)
- Heat deaths vs projected death rates 920.6 (2090)
- Un projection of annual infant deaths 14,569 (2100)
- Population, male, annual growth rate 2.43 % change on previous year (2025)
- Population, male, per unit of GDP 0.0008 units per US$ of GDP (2025)
- Population, male, per capita 0.5016 units per person (2025)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 294,158 (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Madagascar?
- Hepatitis b surface antigen (hbsag) prevalence in Madagascar was 0.6% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Madagascar?
- The highest recorded value was 0.7% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Madagascar?
- The lowest recorded value was 0.5% in 2020.
- How does Madagascar rank for hepatitis b surface antigen (hbsag) prevalence?
- Madagascar ranks 51st out of 192 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Madagascar?
- Over the last ten years it is down 14.3%. The long-run trend across the full record is falling.
- Where does this Madagascar data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).